DENTAL MANAGEMENT OF A PATIENT WITH CARDIOVASCULAR DISEASE

Slides:



Advertisements
Similar presentations
Atherosclerotic coronary vascular disease leading cause of death in the U.S. !! men > 40 y.o. women > 50 y.o. declining rates since 1980 : 42 % !! lifestyle.
Advertisements

M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Disease/Disorders of the Heart. Arrhythmia/ dysrrhythmia BradycardiaTachycardia Any change from normal heart rate or rhythm Slow heart rate (
How can you prevent cardiovascular disease?.  A disease that is not transmitted by another person, vector, or the environment  Habits and behaviors.
Chest Pain The Evolution of a Heart Attack Presented by: Scott G. Popowich, CCEMT-P EMS Coordinator Kodak Rochester Medical Services.
Review Questions and Answers Chapters 10-12
Cardiac Arrhythmia. Cardiac Arrhythmia Definition: The pumping action of the heart is coordinated by an electrical system within the heart tissue.
Ischemic heart disease
Ischemic Heart Diseases IHD
ANGINA MYOCARDIAL INFARCTION HEART BLOCK CONGESTIVE HEART FAILURE DISORDERS OF THE HEART.
DR. HANA OMER.  ANGINA PECTORIS :is a clinical syndrome characterized by paroxysmal chest pain due to transient myocardial ischemia.  It may be occur.
Overview of most common cardiovascular diseases Ahmad Osailan.
BY.DR HINA ADNAN.  Cardiovascular disease is a term that refers to more than one disease of the circulatory system including the heart and blood vessels,
Angina and MI.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Chapter 7: Cardiac Emergencies. 2 AMERICAN RED CROSS FIRST AID–RESPONDING TO EMERGENCIES FOURTH EDITION Copyright © 2006 by The American National Red.
The Heart By: Erin Sawyers. Anatomy Blood Flow Sinus Rhythm  Normal rhythm of a healthy heart  Set by Sinoatrial (SA) Node- natural pacemaker  Normal.
Preventive behaviors can reduce the risk for cardiovascular disease and stroke.
EMS 353. Lectures 6 Dr. Maha Khalid physiology of pharmacology cardiovascular system.
First Aid for Colleges and Universities 10 Edition Chapter 16 © 2012 Pearson Education, Inc. Cardiovascular and Stroke Emergencies Slide Presentation prepared.
1 ANGINA ANGINA MYOCARDIAL OXY. DEMAND >. OXY. SUPPLY. OXY. SUPPLY < SYMPTOMS – chest pain mostly relieved by taking rest, dyspnea, sweating, nausea..
Clinical case no. 22 Presenter: Lin,Huei-Hsiu (Caroline) (Caroline)
2. Ischaemic Heart Disease.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
Dental management of patient with cardiac disease and hypertension by:DR.SUZAN HASSAN Lecture (3).
Types of Angina Pectoris Stable angina Chest or arm discomfort that may not be described as pain but is associated with physical exertion or stess Relieved.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
Interventions for Clients with Cardiac Problems.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Jump to first page Chapter 10 Cardiac Emergencies.
Non-communicable Disease Coronary Heart Disease
Cardiac Emergencies and CPR
REDUCING THE RISKS OF CARDIOVASCULAR DISEASE Lesson 47.
Chapter 5 Cardiac Emergencies.
Dr. Sohail Bashir Sulehria
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Heart Failure Cardiac Insufficiency. What is Heart Failure? Heart failure is a progressive disorder in which damage to the heart causes weakening of the.
Chapter 15: Cardiac Emergencies
Cardiopulmonary Disorders. Common Cardiac Disorders Coronary Artery Disease Myocardial Infarction (MI) Heart Murmurs/Valvular Heart Disease Congestive.
Case Presentation Done by: Lara Abbar Hadeel Al-Shareef Sarah Ghassal Raghad Bajaber Alia Al-Sayed Raghdah Mandili.
Blood Pressure.
©2013 Delmar, Cengage Learning. All Rights Reserved. May not be scanned, copied, duplicated, or posted to a publicly accessible website, in whole or in.
Dental management of patients with cardiovascular diseases
Lesson 11.2 congenital heart disease (CHF) Atherosclerosis
Disease/Disorders of the Heart
Cardiovascular Disease
The Cardiovascular System
Of Cardiovascular diseases
What should dentists know about their patients with heart disease?
口 腔 醫 學 英 文 第一次PBL Oral Medical English
CORONARY ARTERY DISEASE
21 Drugs For Angina Pectoris, Myocardial Infarction, And Cerebrovascular Accident.
Ischemic Heart Disease
Cardiovascular Disease
EVALUATION Evaluation for hypertension has three objectives:
New Paradigm of Anti Anginal Therapy dr.Yerizal Karani SpPD,SpJP(K)
Chapter 28 Management of Patients With Coronary Vascular Disorders
Cardiovascular System Notes
Antianginal Drugs.
Cardiovascular System Diseases
CARDIOVASCULAR AGENTS
CIRCULATORY SYSTEM Characteristics and Treatment of Common Cardiac and Circulatory Disorders.
Cardiovascular Disease (2:22)
Myocardial Infarction
Drugs Used to Treat Angina Pectoris
Presentation transcript:

DENTAL MANAGEMENT OF A PATIENT WITH CARDIOVASCULAR DISEASE بسم الله الرحمن الرحيم DENTAL MANAGEMENT OF A PATIENT WITH CARDIOVASCULAR DISEASE Dr. Mohammed Amjed BDS, MSc, PhD 4/11/2015

ARTERIAL HYPERTENSION ISCHEMIC HEART DISEASE a. Angina pectoris b. Myocardial infarction ARRHYTHMIAS HEART FAILURE coronary artery bypass grafting (CABG) Patients with valvular heart disease

ARTERIAL HYPERTENSION Arterial hypertension is an important health problem due to Its high incidence and prevalence in the general population And the associated increase in risk of suffering cardiovascular disease in the form angina, myocardial infarction and cerebrovascular events like stroke. The blood pressure values considered to be normal were under 140/ 90

Blood pressure is measured with the use of a sphygmomanometer ARTERIAL HYPERTENSION Blood pressure is measured with the use of a sphygmomanometer Systolic pressure = Pressure at the peak of ventricular contraction. Diastolic pressure = the total resting resistance in the arterial system after passage of the pulsating force produced by contraction of the left ventricle.

ARTERIAL HYPERTENSION Oral manifestations No oral complications have been associated with hypertension itself. Patients with malignant hypertension have been reported to occasionally develop facial palsy. Patients with severe hypertension have been reported to bleed excessively after surgical procedures or trauma; however, excessive bleeding in patients with hypertension is not common and is controversial.

Oral manifestations ARTERIAL HYPERTENSION Antihypertensive drugs are able to induce a series of adverse effects with the oral cavity, these includes: # Xerostomia (DIURETICS like furosemide) # Lichenoid reactions (adrenergic blocking agents like propanolol) # Burning mouth sensation (angiotensin -converting enzyme inhibitors like Captopril) # Loss of taste sensation (angiotensin -converting enzyme inhibitors like Captopril) # Gingival hyperplasia, (calcium antagonists Nifedipine ‘Adalat’) # Extraoral manifestations such as sialadenosis (adrenergic blocking agents)

ARTERIAL HYPERTENSION

ARTERIAL HYPERTENSION Dental management - A well controlled hypertensive patients does not pose a risk in clinical practice. - Consultation with the supervising physician is advisable in order to know the degree of hypertension control and the medication prescribed at that time. - The patient is to be instructed to take his or her medication as usual on the day of dental treatment. - Prior to such treatment, the patient blood pressure should be recorded, and if the values are found to be high ( ≥ 180/110) , the visit should be postponed until adequate pressure control is achieved - Cautious use of epinephrine in local anesthetic in patients taking non-selective b-beta blockers or peripheral adrenergic antagonists.

ARTERIAL HYPERTENSION Dental management - Because some antihypertensive agents tend to produce orthostatic hypotension, sudden changes in chair position during dental treatment should be avoided. - It is preferable for the visits to be brief and in the morning. - The prescription of anxiolytic agents may prove necessary in particularly anxious patients (5-10 mg of diazepam the night before and 1-2 hours before the appointment) before dental treatment, or altaernatively sedation with nitrous oxide may be considered. - Vasoconstrictor use should be limited, taking care not to exceed 0.04 mg of adrenaline (2 carpules containing 1.8 ml of anesthetic with adrenalin 1: 100,000)

ARTERIAL HYPERTENSION Dental management - A good local anesthetic technique should be performed, avoiding intravascular injection and using a maximum of two anesthetic carpules with vasoconstrictor. If more anesthesia is needed, it should be provided without vasoconstrictor. Absorbable suture are to be avoided with adrenalin. - When the patient does not present good blood pressure control, it is best to refer him or her to the physician in order to ensure adequate control before dental treatment. - In the case of emergency dental visits, treatment should be conservative, with the use of analgesics and antibiotics. - Surgery is to be avoided until adequate blood pressure control has been secured.

ARTERIAL HYPERTENSION Dental management Certain nonsteroidal antiinflammatory drugs (NSAIDs), such as ibuprofen, indomethacin or the naproxen, can interact with antihypertensive drugs (beta-blockers, diuretics), thereby lowering their antihypertensive action. Normally more than five days of treatment with both types of drugs are required for interactions to manifest; as a result, NSAIDs should not be prescribed for longer than this five-day period. - Avoid NSAID because of their renal effects which cause retention of sodium and water that lead to raise in the blood pressure.

ARTERIAL HYPERTENSION Dental management/ Hypertensive emergencies In the case of a hypertensive emergency (>120/210 mmHg), the emergency management done by furosemide should be administered (40 mg, via the oral route). If this proves insufficient to restore pressure control, captopril should be administered (25 mg via the oral or sublingual route). If the blood pressure fails to decrease within 30 minutes after these measures, the patient should be referred to the nearest Hospital Emergency Department.

ISCHEMIC HEART DISEASE Ischemic heart disease is the main cause of death in the developed world. Ischemic heart disease is characterized by a reduction (partial or total) in coronary blood flow. In 90% of all cases, this occurs following thrombus formation secondary to an atheroma plaque that occludes the arterial lumen, though other factors such as cold, physical exercise or stress can act as co-adjuvant factors or (less frequently) trigger the event themselves. Chest pain (angina) occurs when coronary occlusion is partial and no myocardial necrosis is produced, while acute myocardial infarction is observed when coronary occlusion is total and necrosis is produced as a result. In turn, sudden death may also occur, generally as a result of arrhythmias. The dental environment increases the likelihood of an anginal attack because of associated fear, anxiety or pain.

Angina pectoris Stable angina VS Unstable angina

1. Angina pectoris Stable angina: it is described as an aching, heavy, squeezing pressure or tightness in the mid chest region (1-3 minutes). The area of discomfort often is described to be approximately the size of the fist and may radiate into the left or right arm to the neck or lower jaw. preceded by physical exertion or emotional stress. This pain subsides with rest and/or the administration of sublingual nitroglycerin. Unstable angina: it typically manifests under resting conditions, is characterized by more intense pain with a duration of no more than 20-30 minutes, and a poorer response to nitrates. This presentation can soon evolve towards myocardial infarction.

1. Angina pectoris Prinzmetal angina: is a syndrome typically consisting of angina at rest that occurs in cycles. It is caused by vasospasm, a narrowing of the coronary arteries caused by contraction of the smooth muscle tissue in the vessel walls rather than directly by atherosclerosis (buildup of fatty plaque and hardening of the arteries).

2. Myocardial infarction (AMI) Acute myocardial infarction is characterized by acute, sudden onset and intense pain, of an oppressive nature, located in the retrosternal or precordial region, and can irradiate to the arms, neck, back, jaw, palate or tongue. The duration is over half an hour, and the pain does not subside with rest. The condition is accompanied by intense perspiration, nausea, vomiting, dyspnea and imminent death sensation, though it can also manifest as sudden loss of consciousness, mental confusion or weakness.

Acute myocardial infarction (AMI) The triggering stimuli are emotional stress, intense physical exercise or the existence of concomitant disease or surgery. The drugs used to treat AMI and administered for secondary prevention purposes comprise beta-blockers, calcium antagonists and the angiotensin-converting enzyme inhibitors.

Acute myocardial infarction (AMI) Oral manifestations If the patient is receiving anticoagulant or antiplatelet treatment, bleeding may occur, manifesting as hematomas, petechiae or gingival bleeding.

Ischaemic heart disease IHD Dental management - A patient who has suffered acute myocardial infarction is at a high risk of suffering another infarction episode or severe arrhythmias. It has been reported that over 70% of all recurrences take place in the first month after the initial vascular event. - In dental practice a minimum safety period of 6 months has been established before any oral surgical procedure can be carried out. However, studies in recent years have underscored the need to revise these criteria. No ideal minimum time has been established, though many authors consider 4-6 weeks after infarction to be a prudent period. - In this time, dental treatment should be limited to emergency procedures aimed at affording pain relief: extractions, the drainage of abscesses and pulpectomies, preferably carried out in the hospital setting.

Ischaemic heart disease IHD Dental management - If more than 6 months have elapsed or physician clearance is obtained, the management of the patient who has had an MI is similar to care of the patient with angina.

Acute myocardial infarction (AMI) Dental management - Consultation with the supervising physician is advised in order to know the type of heart disease (angina or infarction), its severity, the time elapsed from the cardiological event, the clinical complications, and the treatment received by the patient. - The patient should continue taking the prescribed medication as usual. If nitrates are used, the patient should bring them to each visit to the dental clinic, in case chest pain develops. - Some authors mention the possibility of administering nitrite as a preventive measure before local anesthesia.

Ischaemic heart disease IHD Dental management - In the case of very anxious patients, premedication can be administered to lessen anxiety and stress (5-10 mg of diazepam the night before and 1-2 hours before treatment). - The visits should be brief (less than 30 minutes) and should be programmed for during the day – avoiding the early morning hours, which is when heart attacks are most frequent, as well as the late afternoon hours, when tiredness and stress are greater. - A good anesthetic technique is required, taking care not to inject the solution into a blood vessel, and using a maximum of two carpules with vasoconstrictor. In turn, if anesthetic reinforcement is needed, it should be provided without a vasoconstrictor.

Ischaemic heart disease IHD Dental management - The patient should be placed in the position most comfortable for him or her (semi supine), and should get up carefully in order to avoid orthostatic hypotension. - Depending on the patient, blood pressure and pulsioxymetric monitoring may be required before and during dental treatment. - If the patient is receiving anticoagulants, the international normalized ratio (INR) on the day of treatment should be determined, and treatment should be provided within the recommended limits (< 3.5), with local hemostasis if surgery is planned.

Ischaemic heart disease IHD Dental management - If the patient develops chest pain during dental treatment, the procedure should be suspended immediately, and a sublingual nitrite tablet should be administered (0.4-0.8 mg), together with nasal oxygen (3 liters/minute). If the pain subsequently subsides, continuation of treatment can be considered, or alternatively an appointment can be made for some other day. If the pain fails to subside after 5 minutes, a second sublingual tablet should be administered. If the pain fails to disappear 15 minutes after onset, acute myocardial infarction is to be suspected, and the patient must be transferred to a hospital center.

Ischaemic heart disease IHD Dental management

ARRHYTHMIAS

Atrial fibrillation is the most common type of cardiac arrhythmia. ARRHYTHMIAS - Arrhythmias are variations in normal heart rate due to disorders of (1) cardiac rhythm, (2) frequency or (3) contraction. Atrial fibrillation is the most common type of cardiac arrhythmia. The frequency of electric pulse generation in the sinus node ranges from 60-80 beats per minute (bpm) under resting conditions and can increase to 200 bpm during physical exercise. Arrhythmias are generated when electric pulse generation proves defective.

ARRHYTHMIAS Oral manifestations Many antiarrhythmic drugs have side effects such as gingival hyperplasia or xerostomia.

# It must be checked that the patient uses the medication correctly. ARRHYTHMIAS Dental management # Consultation with the supervising physician is advised in order to know the current condition of the patient and the type of arrhythmia involved, as well as the medication prescribed. # It must be checked that the patient uses the medication correctly. # Anxiolytics can be used to lessen stress and anxiety. # Short visits in the morning are to be preferred. # Patient monitoring, with recording of the pulse, is indicated before starting treatment. # It is very important to limit the use of a vasoconstrictor in local anesthesia, with the administration of no more than two carpules. # The treatment planned should not be too long or complicated.

ARRHYTHMIAS Dental management modern pacemakers are more resistant to electromagnetic interferences, however caution is required when using electrical devices (e.g., ultrasound and electric scalpels) that might interfere with pacemakers particularly the older models, since most such devices developed in the last 30 years are bipolar and are generally not affected by the small electromagnetic fields generated by dental equipment. It is therefore important to know the type of pacemaker, the degree of electromagnetic protection of the generator, and the nature of the arrhythmia. Pacemakers and automatic defibrillators pose a low risk of infectious endocarditis, and do not need antibiotic coverage before dental treatment.

ARRHYTHMIAS Dental management If important arrhythmia develops during dental treatment the procedure should be suspended oxygen is to be provided and the patient vital signs are to be assessed: a. Body temperature (normal values: 35.5-37ºC) b. Pulse (normal values: 60-100 bpm) c. Respiratory frequency (normal values in adults: 14-20 cycles or respirations per minute) d. Blood pressure (normal values: systolic blood pressure under 140 mmHg and diastolic blood pressure under 90 mmHg). Sublingual nitrites are to be administered in the event of chest pain. The patient should be placed in the Trendelenburg position, with vagal maneuvering where necessary (Valsalva maneuver, massage in the carotid pulse region, etc.). The dental team should be prepared for basic cardiopulmonary resuscitation and initiation of the emergency procedure for evacuation to a hospital center, if necessary.

within the lungs, liver and peripheral tissues. HEART FAILURE - Heart failure (HF) is defined as the incapacity of the heart to function properly, pumping insufficient blood towards the tissues and leading to fluid accumulation within the lungs, liver and peripheral tissues. - Heart failure in turn is the end stage of other diseases such as ischemic heart disease or arterial hypertension. - The most common causes are severe and prolonged arterial hypertension, valve disease, ischemic heart disease and serious pericardial diseases.

HEART FAILURE Oral manifestations Due to the drug treatments used by patients with heart failure, a series of oral manifestations can be observed. In this context, ACEIs (captopril) can produce lichenoid reactions, burning mouth sensation and a loss of taste sensation, while diuretics (furosemide) can produce xerostomia.

HEART FAILURE Dental management - Consultation with the supervising physician is advised in order to know the current condition of the patient and the medication prescribed. The patient should be receiving medical care, and heart failure should be compensated. - Dental treatment is to be limited to patients who are in stable condition, since these individuals are at an important risk of developing serious arrhythmias and even sudden death secondary to cardiopulmonary arrest. - In patients with heart failure, including those presenting palpitations, asthenia or dyspnea, it is important to only provide emergency care, and to do so in the hospital setting.

HEART FAILURE Dental management - Anxiety and stress are to be avoided during the visits, which in turn should be brief (less than 30 minutes) and are to be programmed for the morning hours. The patient should be placed in the semi-supine position in a chair, with control of body movements (which should be slow), in order to avoid orthostatic hypotension. - In patients administered digitalis agents (digoxin, methyldigoxin), the vasoconstrictor dose is to be limited to two anesthetic carpules, since this drug combination can favor the appearance of arrhythmias. Aspirin can lead to sodium and fluid retention, and therefore should not be prescribed in patients with heart failure.

ENDOCARDITIS Infectious endocarditis (IE) is an infrequent condition resulting from the association of morphological alterations of the heart and bacteremia of different origins. The mortality rate is 5-11%

Transient bacteremia is observed in: ENDOCARDITIS Transient bacteremia is observed in: dental treatments such as tooth extractions (51-85%) periodontal surgery (36-88%) during tooth brushing (26%) when chewing gum (17-51%).

coronary artery bypass grafting (CABG) In general, with respect to major oral surgical care, patients who have had coronary artery bypass grafting (CABG) are treated in a manner similar to patients who have had an MI. Before major elective surgery is performed, 3 months are allowed to elapse. If major surgery is necessary earlier than 3 months after the CABG, the patient’s physician should be consulted. Patients who have had CABG usually have a history of angina, MI, or both and therefore should be managed as previously described. Routine office surgical procedures may be safely performed in patients less than 6 months after CABG surgery if their recovery has been uncomplicated and anxiety is kept to a minimum.

• The risk of infective endocarditis Patients with valvular heart disease There are two main concerns during dental treatment of patients with valvular disease: • The risk of infective endocarditis • The risk of bleeding in anticoagulated patients.

Patients with valvular heart disease

Patients with valvular heart disease

END